Europe - Euronext Paris - EPA:DIM - FR0013154002 - Common Stock
The current stock price of DIM.PA is 208.2 EUR. In the past month the price increased by 0.39%. In the past year, price increased by 14.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 48.7 | 20.43B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 54.34 | 18.56B | ||
| SRT.DE | SARTORIUS AG | 42.63 | 14.56B | ||
| QIA.DE | QIAGEN N.V. | 19.02 | 8.33B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.18 | 2.22B | ||
| EVT.DE | EVOTEC SE | N/A | 1.96B | ||
| GXI.DE | GERRESHEIMER AG | 7.53 | 960.21M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.72 | 210.45M |
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,134 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
SARTORIUS STEDIM BIOTECH
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Aubagne PACA FR
Employees: 9961
Phone: 33442845600
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,134 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
The current stock price of DIM.PA is 208.2 EUR. The price decreased by -0.86% in the last trading session.
SARTORIUS STEDIM BIOTECH (DIM.PA) has a dividend yield of 0.34%. The yearly dividend amount is currently 0.71.
DIM.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
SARTORIUS STEDIM BIOTECH (DIM.PA) operates in the Health Care sector and the Life Sciences Tools & Services industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DIM.PA.
You can find the ownership structure of SARTORIUS STEDIM BIOTECH (DIM.PA) on the Ownership tab.
ChartMill assigns a technical rating of 7 / 10 to DIM.PA. When comparing the yearly performance of all stocks, DIM.PA is one of the better performing stocks in the market, outperforming 71% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to DIM.PA. Both the profitability and the financial health of DIM.PA get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months DIM.PA reported a non-GAAP Earnings per Share(EPS) of 4.31. The EPS increased by 35.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.96% | ||
| ROA | 3.35% | ||
| ROE | 6.54% | ||
| Debt/Equity | 0.5 |
18 analysts have analysed DIM.PA and the average price target is 245.19 EUR. This implies a price increase of 17.77% is expected in the next year compared to the current price of 208.2.
For the next year, analysts expect an EPS growth of 29.39% and a revenue growth 7.45% for DIM.PA